Services

Biochemical Analysis and Lipoprotein Production Lab

Presentation

3 services for both external and internal customers:

  • Biochemical analysis in biofluids by an autoanalyzer (COBAS c501/c6000).
  • Quantitative and functional characterization of lipoproteins.
  • Preparation and sale of human native and modified lipoproteins.

Services

The services that we offer are:

1. Determination of biochemical parameters of samples (cell supernatants, serum, plasma, urine) by autoanalyzer (COBAS c501/c6000):

  • Apo A-I
  • Apo B100
  • Apo E
  • Apo A-II
  • Apo C-II
  • Apo C-III
  • Albumin
  • Alkaline phosphatase
  • Alanine aminotransferase (ALT) (GPT)
  • Amylase
  • Aspartate aminotransferase (AST) (GOT)
  • Bilirubin
  • Cholesterol (total, LDL and HDL cholesterol)
  • Creatine kinase (CK)
  • Creatinine
  • C-reactive protein
  • D-dimer
  • Ferritin
  • Fructosamine
  • Free fatty acids (FFA)
  • Gamma glutamyl transferase (GGT)
  • Glucose
  • Glycerol
  • Haptoglobin
  • HbA1c
  • Lactate deshidrogenase (LDH)
  • Lipase
  • Lipoprotein (a)
  • Transferrin
  • Tryglicerides
  • Urea
  • Urine proteins

2. Functional characterization of plasma lipoproteins:

  • Antioxidant ability of HDL
  • Lipoprotein-associated phospholipase A2 activity (total or in lipoproteins)
  • LDL subfractions
  • Paraoxonase 1 activity
  • Susceptibility to oxidation (LDL and HDL)
  • VLDL, LDL, and HDL composition (mice and human)

3. Supply of purified lipoproteins (native, modified or labeled) for research:

  • ApoA-I (free)
  • Acetylated LDL
  • DiI-LDL
  • Electronegative LDL
  • Glycated LDL
  • Oxidized LDL
  • VLDL (d < 1.006 mg/ml)
  • IDL (1.006-1.019)
  • LDL (1.019-1.063)
  • LDL (1.019-1.050)
  • HDL (1.063-1.210)

Experience and Trajectory

The lead investigators of this initiative have extensive years of experience studying lipid and lipoprotein metabolism.

Research Projects:

  • ISCIII PI17/00232, PI16/00139, PI16/00471
  • Fundació La Marató 2016, 201602.31
  • Ministry of Science, Innovation and Universities (PID2019-104367RB-100)

Publications:

  • Changes in the Composition and Function of Lipoproteins after Bariatric Surgery in Patients with Severe Obesity. Genua I, et al. J Clin Med. 2021 Apr
    16;10(8):1716.
  • LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models. Cedó L, et al. Circ Res. 2020 Aug 28;127(6):778-792.
  • Familial Combined Hyperlipidemia (FCH) Patients with High Triglyceride Levels Present with Worse Lipoprotein Function Than FCH Patients with Isolated Hypercholesterolemia. Puig N, et al. Biomedicines. 2020 Jan 6;8(1):6.
  • Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice. Rivas-Urbina A, et al. Biomolecules. 2020 May 29;10(6):829.
  • Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice. Méndez-Lara KA, et al. Antioxidants (Basel). 2020 Nov 21;9(11):1162.

Equipment

Equipment involved in providing the service:

  • Cobas 6000/c501 Autoanalyzer (Hitachi)
  • Synergy HT Fluorimeter (Biotek)
  • NGC Chromatography System (BioRad)

Responsibles

Contact mail:  jsanchezq@santpau.cat

default-member
Jose Luis Sanchez Quesada

Scientific Responsible

default-member
Sonia Benitez Gonzalez

Technical Responsible

default-member
Juan Carlos Escola Gil

Manager Responsible